Stage 1 osteosarcoma is usually localized and has not spread to nearby lymph nodes or distant organs. Early-stage disease is ...

The narrative emphasizes the critical role of a supportive partner in managing chronic small lymphocytic lymphoma over 16 ...

TKI-based regimens remain the primary approach for metastatic renal cell carcinoma after immune checkpoint inhibitor therapy, ...

Higher body mass index (BMI) after diagnosis is linked to better survival outcomes in patients with localized renal cell ...

FOG-001 received fast track designation after early study results showed tumor shrinkage in all evaluable patients with ...

Dr. Joshua Sabari sat down with Dr. Michael Cecchini to discuss advances in colorectal cancer management and key data ...

When Cindy Mrotek and Katie Glenn each became caregivers for their parents with cholangiocarcinoma, they had no idea the ...

Cancerguard detects multiple cancers early by identifying specific DNA and protein markers in a blood sample. The test is ...

The U.S. Food and Drug Administration (FDA) approved Poherdy (pertuzumab-dpzb) as the first interchangeable biosimilar to ...

Breast cancer advancements include targeted therapies, oral medications for ER-positive/HER2-negative populations, and ...

Kidney cancer incidence is 90% higher in American Indian and Alaska Native populations than in non-Hispanic Whites, with mortality rates nearly double. Disparities are driven by late detection, ...

The trial showed that 63% of patients achieved a complete response (CR) at any time after receiving detalimogene coraplasmid.